PALO ALTO, Calif.–(Business Phone)–Thermo Fisher Scientific has updated its core Applied Biosystems Chromosome Analysis Suite (ChAS) software through a partnership with Genoox, a community-driven genomic data company. ChAS users can access Genoox’s cloud-based AI platform, Franklin, and the launch of CytoScan’s Automated Interpretation and Reporting (AIR) solution, to simplify cytogenetic research data analysis.
By automating interpretation and reporting, ChAS and Franklin provide a clear and simple workflow for rapid access to consistent cytogenetic analysis results. While manual translation takes time, ChAS users can get accurate results in just seconds.
“We developed the ChAS software with the input of leading cytogeneticists and continue to work with our customers to make the data easier and more intuitive,” said Chad Carter, vice president and general manager. , microarrays gene solutions, Thermo Fisher Scientific. “By partnering with Genoox, we will make data interpretation easier so our customers can focus on their research.”
“We are excited to partner with Thermo Fisher Scientific, a leader in cytogenetics,” said Amir Trabelsi, CEO and founder of Genoox. “We created Franklin to advance genomic medicine by giving users access to real-time, real-time genomic data. The combination of ChAS and Franklin continues this mission and we hope We open the program to ChAS users.
Genoox leverages the power of its community to provide insights from the world’s largest real-time genomic database serving professionals in the field of care. Genoox’s cloud-based AI platform, Franklin, connects physicians, genetic counselors and healthcare organizations, while platform users can create meaningful insights using tools and advanced genetic applications. Genoox is used by more than 2,100 healthcare organizations, hospitals and pharmacies in 46 markets worldwide. Visit our website for more information at: www.genoox.com.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. world leader in science, with annual revenues of nearly $40 billion. Our Mission is to enable our customers to make the world better, cleaner and safer. Whether our customers are accelerating life-saving research, solving complex diagnostic challenges, increasing productivity in their laboratories, improving patient health through diagnostics, or development and manufacturing of life-changing medicines, we are here to support them. Our global team delivers a combination of innovative technology, flexible sales and medical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, visit www.thermofisher.com.